Clinical Trial Update: Effects of Ulinastatin on Myocardial Protection and Blood Loss in Patients Undergoing Aortic Valve Replacement [Phase 4]

View source ↗

Summary

Phase 4 clinical trial assessing whether Ulinastatin improves myocardial protection and reduces blood loss in patients undergoing aortic valve replacement.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aortic Valve Disease

Drugs mentioned

• Ulinastatin (ulinastatin)

Snippet

Sponsor: Yonsei University | Conditions: Abnormal Aortic Valve | Phase 4 | Status: COMPLETED